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Abstract
Background: Neuroleptic induced extrapyramidal disorders are often presented in a form of
orofacial hyperkinesias and dystonia. Rational use of neuroleptic drugs requires individualised
approach to a patient, however simple criteria for determining individual, 'personalised' dosage
regimen have not been fully developed for routine practice in resource-limited hospital settings.
Objective: To study the tonus of tongue muscles as a measure of orofacial dystonia and the total
hepatic oxidative capacity as a potential predictor of excessive vulnerability to neuroleptic-
induced dystonia in psychiatric  patients.  Methods:  We measured the maximal force of  the
tongue manoeuvre (F, g/cm 2), the total (integral) hepatic oxidative capacity by the antipyrine-
test and used chlorpromazine equivalent to calculate the total daily neuroleptic load in 283
psychiatric patients and 30 healthy volunteers. Results: The tonus of tongue muscles depends
on the total daily neuroleptic dose and the length of antipsychotic treatment. The higher the
total  daily  neuroleptic  dose and the longer  the treatment  history,  the greater  the tongue
muscles' tonus is. The tongue muscles' tonus was greater in patients with low rate of oxidative
antipyrine  metabolism.  Antidepressants  contributed  to  the  increased  tonus  of  the  tongue
muscles in 'slow metabolisers' of antipyrine. Conclusions: The simple and cheap measurements
of total hepatic oxidative capacity and of muscle tonus of the tongue could be used to predict
and manage neuroleptic-induced adverse reactions.  © 2013-IOS Press and the authors.  All
rights reserved.
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